Trial Profile
Evaluation of the clinical efficacy and safety of the combined administration of Imidafenacin and alfa1-blocker in BPH patients with OAB.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 19 Dec 2016
Price :
$35
*
At a glance
- Drugs Imidafenacin (Primary) ; Alpha 1 adrenergic receptor antagonists
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- Acronyms FUN Study
- 21 May 2012 New trial record